Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

EMBC

Embecta Corp

Feb 13 • 04:00PM ET

10.17

+0.17 1.70 %

Healthcare • Medical Instruments & Supplies • USA • NASD

Peers: DXCM PODD TNDM ABT MDT LCTX VTRS BAX BMY MRK

| Held by: IJR VTI IWM VXF FNDA IJS SPSM IWN VTWO SLYV

Index	RUT	P/E	4.29	EPS (ttm)	2.37	Insider Own	7.59%	Shs Outstand	59.21M	Perf Week	-6.40%
Market Cap	602.27M	Forward P/E	3.53	EPS next Y	2.88	Insider Trans	0.00%	Shs Float	54.72M	Perf Month	-20.24%
Enterprise Value	1.81B	PEG	10.39	EPS next Q	0.42	Inst Own	94.02%	Short Float	7.08%	Perf Quarter	-29.86%
Income	139.50M	P/S	0.56	EPS this Y	-4.58%	Inst Trans	-2.34%	Short Ratio	5.27	Perf Half Y	-26.68%
Sales	1.08B	P/B	-	EPS next Y	2.31%	ROA	12.61%	Short Interest	3.87M	Perf YTD	-14.39%
Book/sh	-10.35	P/C	2.95	EPS next 5Y	0.34%	ROE	-	52W High	16.75 -39.30%	Perf Year	-37.03%
Cash/sh	3.45	P/FCF	2.93	EPS past 3/5Y	-25.52% -	ROIC	17.94%	52W Low	9.20 10.54%	Perf 3Y	-64.23%
Dividend Est.	0.60 (5.90%)	EV/EBITDA	4.54	Sales past 3/5Y	-1.47% -0.10%	Gross Margin	63.73%	Volatility	4.62% 6.07%	Perf 5Y	-
Dividend TTM	0.60 (5.90%)	EV/Sales	1.67	EPS Y/Y TTM	136.26%	Oper. Margin	32.06%	ATR (14)	0.64	Perf 10Y	-
Dividend Ex-Date	Feb 27, 2026	Quick Ratio	1.87	Sales Y/Y TTM	-2.53%	Profit Margin	12.92%	RSI (14)	37.42	Recom	2.75
Dividend Gr. 3/5Y	58.74% -	Current Ratio	2.64	EPS Q/Q	-	SMA20	-6.54%	Beta	1.07	Target Price	16.67
Payout	37.05%	Debt/Eq	-	Sales Q/Q	-0.27%	SMA50	-11.99%	Rel Volume	1.45	Prev Close	10.00
Employees	1850	LT Debt/Eq	-	Earnings	Feb 05 BMO	SMA200	-17.14%	Avg Volume	734.35K	Price	10.17
IPO	Mar 22, 2022	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.81% 1.21%	Trades		Volume	1,062,309	Change	1.70%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-10-25	Initiated	Mizuho	Neutral	$15
Dec-02-24	Upgrade	Morgan Stanley	Underweight → Equal-Weight	$13 → $20
Nov-27-24	Upgrade	BTIG Research	Neutral → Buy	$26
Oct-20-23	Initiated	Wolfe Research	Peer Perform
Jan-06-23	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$28
Sep-08-22	Initiated	BTIG Research	Neutral
Aug-01-22	Initiated	Morgan Stanley	Equal-Weight	$33
Jun-21-22	Initiated	BofA Securities	Underperform	$25

Feb-11-26 04:10PM	embecta names new Chairman of the Board and Lead Independent Director (GlobeNewswire)
Feb-05-26 05:30PM	Embecta Q1 Earnings Call Highlights (MarketBeat) -7.75%
02:02PM	Embecta Corp (EMBC) Q1 2026 Earnings Call Highlights: Strategic Progress Amidst Market Challenges (GuruFocus.com)
06:30AM	Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
05:00PM	Loading…
Jan-22-26 05:00PM	embecta to Report Fiscal First Quarter Financial Results (GlobeNewswire) -9.44%
Dec-18-25 05:00PM	embecta to Participate at the J.P. Morgan 2026 Healthcare Conference (GlobeNewswire)
Nov-25-25 02:01PM	Embecta Corp (EMBC) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Revenue Challenges (GuruFocus.com) -7.24%
06:30AM	Embecta Corp. Reports Fiscal 2025 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2026 Financial Guidance (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Nov-20-25 07:50AM	EMBC Q4 Preview: Product Momentum and Strategy Gains to Support Growth? (Zacks)
Nov-17-25 05:00PM	embecta announces changes to Board of Directors (GlobeNewswire)
Nov-14-25 06:30AM	embecta Announces Major New Commitment to Direct Relief on World Diabetes Day (GlobeNewswire)
Nov-11-25 05:00PM	embecta to Report Fiscal Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Oct-06-25 05:15AM	Best Value Stocks to Buy for October 6th (Zacks)
08:06AM	Loading…
Sep-15-25 08:06AM	Best Income Stocks to Buy for September 15th (Zacks)
05:37AM	New Strong Buy Stocks for September 15th (Zacks)
Sep-09-25 04:12AM	Best Value Stocks to Buy for September 9th (Zacks)
Aug-26-25 05:00PM	embecta to Participate in Investor Events (GlobeNewswire)
Aug-25-25 09:30AM	Embecta Corp. (EMBC) Crossed Above the 200-Day Moving Average: What That Means for Investors (Zacks)
Aug-12-25 09:55AM	Wall Street Analysts Predict a 25.69% Upside in Embecta Corp. (EMBC): Here's What You Should Know (Zacks)
Aug-09-25 03:03AM	Embecta Corp (EMBC) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic Progress ... (GuruFocus.com)
Aug-08-25 06:30AM	Embecta Corp. Reports Third Quarter Fiscal 2025 Financial Results (GlobeNewswire) +18.53%
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Jul-24-25 05:00PM	embecta to Report Fiscal Third Quarter 2025 Financial Results (GlobeNewswire)
Jul-13-25 12:27AM	BTIG Lowers PT on Embecta Corp. (EMBC) to $25, Keeps a Buy Rating (Insider Monkey)
Jul-10-25 11:13AM	Mizuho Lowers PT on Embecta Corp. (EMBC) to $13 From $15, Keeps a Neutral Rating (Insider Monkey)
May-27-25 05:00PM	embecta to Participate in Investor Events (GlobeNewswire) +5.09% -6.31%
May-22-25 06:30AM	embecta to Showcase Phased Approach for Value Creation and Present Long Range Financial Plan at 2025 Analyst and Investor Day (GlobeNewswire) -14.97%
May-13-25 10:50AM	Embecta restructures again, outlines tariff costs (MedTech Dive)
05:16AM	Loading…
May-10-25 05:16AM	Q2 2025 Embecta Corp Earnings Call (Thomson Reuters StreetEvents)
03:03AM	Embecta Corp (EMBC) Q2 2025 Earnings Call Highlights: Strategic Growth Amid Revenue Decline (GuruFocus.com)
May-09-25 12:10PM	Why Is Embecta Stock Falling On Friday? (Benzinga) -10.00%
07:40AM	Embecta Corp. (EMBC) Tops Q2 Earnings Estimates (Zacks)
06:30AM	Embecta Corp. Reports Second Quarter Fiscal 2025 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
May-08-25 05:15PM	Solventum (SOLV) Tops Q1 Earnings and Revenue Estimates (Zacks) +6.66%
May-07-25 11:35AM	2024 Total Dividend Income And Portfolio Update (Seeking Alpha)
Apr-28-25 07:30AM	Embecta to host Analyst and Investor Day on May 22, 2025 (GlobeNewswire)
Apr-22-25 03:51AM	Beyond the drug: Closing the knowledge gap for injectable diabetes meds (Pharma Voice)
Apr-21-25 05:00PM	embecta to Report Fiscal Second Quarter 2025 Financial Results (GlobeNewswire)
Apr-01-25 08:05AM	Mayo Clinic Proceedings Publishes New Global Insulin Injection Recommendations (GlobeNewswire)
Feb-19-25 03:36PM	Embecta Corp. (EMBC): Among Last Weeks Worst Dividend Stocks (Insider Monkey)
Feb-18-25 05:00PM	embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference (GlobeNewswire)
Feb-07-25 02:09AM	Embecta Corp (EMBC) Q1 2025 Earnings Call Highlights: Navigating Revenue Declines and Strategic ... (GuruFocus.com)
Feb-06-25 07:45AM	Embecta Corp. (EMBC) Tops Q1 Earnings and Revenue Estimates (Zacks)
06:30AM	Embecta Corp. Reports First Quarter Fiscal 2025 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Jan-23-25 05:00PM	embecta to Report Fiscal First Quarter 2025 Financial Results (GlobeNewswire)
Dec-19-24 05:00PM	embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-09-24 08:50AM	Here Is Why Bargain Hunters Would Love Fast-paced Mover Embecta Corp. (EMBC) (Zacks)
Dec-06-24 06:00AM	Embecta to cut 125 jobs after ending insulin patch pump (MedTech Dive)
Nov-27-24 06:40AM	Embecta to discontinue insulin patch pump program, initiates restructuring plan (TipRanks) +10.11%
02:02AM	Embecta Corp (EMBC) Q4 2024 Earnings Call Highlights: Strategic Shifts and Financial Performance (GuruFocus.com)
12:26AM	Q4 2024 Embecta Corp Earnings Call (Thomson Reuters StreetEvents)
Nov-26-24 01:15PM	Becton Dickinson Spinoff Embecta Stops Insulin Patch Pump Program, Plans Restructuring, Stock Jumps (Benzinga) +29.77%
07:40AM	Embecta Corp. (EMBC) Tops Q4 Earnings and Revenue Estimates (Zacks)
06:40AM	Embecta discontinues insulin patch pump development (MedTech Dive)
06:30AM	Embecta Corp. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance; Discontinues Insulin Patch Pump Program; and Announces Restructuring to Streamline Operations and Reduce Costs (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Nov-18-24 10:00AM	Inside a $400 billion bet on the brain-computer interface revolution (Yahoo Finance)
Nov-12-24 05:31PM	UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
05:00PM	embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Nov-07-24 06:30AM	embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell (GlobeNewswire) -6.37%
Sep-03-24 07:55AM	Embecta gets FDA nod for insulin patch pump (MedTech Dive)
06:30AM	embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes (GlobeNewswire)
Aug-22-24 05:00PM	embecta to Participate in Investor Events (GlobeNewswire) +6.14%
Aug-12-24 09:35AM	Embecta Corp. (EMBC) Recently Broke Out Above the 20-Day Moving Average (Zacks)
09:30AM	Embecta Corp. (EMBC) Just Overtook the 200-Day Moving Average (Zacks)
Aug-10-24 08:18AM	Embecta Corp. (NASDAQ:EMBC) Q3 2024 Earnings Call Transcript (Insider Monkey)
Aug-09-24 10:52AM	EMBC Stock Earnings: Embecta Beats EPS, Beats Revenue for Q3 2024 (InvestorPlace) +7.32%
07:40AM	Embecta Corp. (EMBC) Tops Q3 Earnings and Revenue Estimates (Zacks)
06:30AM	Embecta Corp. Reports Third Quarter Fiscal 2024 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Aug-02-24 10:00AM	Earnings Preview: Embecta Corp. (EMBC) Q3 Earnings Expected to Decline (Zacks)
Jul-31-24 09:47AM	Is the Options Market Predicting a Spike in Embecta Corp. (EMBC) Stock? (Zacks)
Jul-29-24 08:05AM	Genpact Supports embecta's Spin-Off into an Independent Diabetes Care Company (PR Newswire)
Jul-24-24 04:21AM	Strength Seen in Embecta Corp. (EMBC): Can Its 6.9% Jump Turn into More Strength? (Zacks)
Jul-22-24 07:42AM	Diabetes device firm Embecta considers sale: Financial Times (MedTech Dive) +15.26%
Jul-18-24 05:00PM	embecta to Report Fiscal Third Quarter 2024 Financial Results (GlobeNewswire)
Jun-25-24 07:47AM	Embecta touts its insulin patch pump at ADA (MedTech Dive)
Jun-24-24 06:30AM	embecta-sponsored Abstracts Presented at American Diabetes Association's 84th Scientific Sessions Highlight Unmet Need for Patch Pumps with 300u Insulin Reservoir (GlobeNewswire)
Jun-20-24 07:30AM	Zimmer Biomet Announces Appointment of Devdatt Kurdikar to Board of Directors (PR Newswire)
May-21-24 04:30PM	Trade Winds Turning: 3 Stocks Poised to Gain from Biden's China Tariffs (InvestorPlace)
May-13-24 11:52AM	Embecta Corp. (NASDAQ:EMBC) Q2 2024 Earnings Call Transcript (Insider Monkey)
May-10-24 02:12PM	Embecta Corp (EMBC) Surpasses Analyst Revenue Forecasts in Q2 Fiscal 2024 (GuruFocus.com)
May-09-24 10:54AM	EMBC Stock Earnings: Embecta Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace) +37.88%
06:30AM	Embecta Corp. Reports Second Quarter Fiscal 2024 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
May-01-24 05:00PM	embecta to Participate in Investor Events (GlobeNewswire)
Apr-23-24 05:00PM	embecta to Report Fiscal Second Quarter 2024 Financial Results (GlobeNewswire)
Mar-06-24 06:00AM	embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes (GlobeNewswire)
Feb-10-24 08:55AM	Embecta Corp. (NASDAQ:EMBC) Q1 2024 Earnings Call Transcript (Insider Monkey)
Feb-09-24 10:07PM	Q1 2024 Embecta Corp Earnings Call (Thomson Reuters StreetEvents) -8.47% -7.91%
11:43AM	Why Embecta Stock Is Tanking Today (Motley Fool)
07:45AM	Embecta Corp. (EMBC) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
07:07AM	Embecta Corp (EMBC) Reports Modest Revenue Growth and Decline in Profitability in Q1 Fiscal 2024 (GuruFocus.com)
06:30AM	Embecta Corp. Reports First Quarter Fiscal 2024 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Feb-07-24 05:00PM	embecta to Participate in the 11th Annual BTIG MedTech Conference (GlobeNewswire)

Embecta Corp. engages in the provision of medical devices used in the treatment of diabetes. Its products include pen needles, syringes, and safety devices complemented by a digital application. The company was founded in 1924 and is headquartered in Parsippany, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Melcher David F	Director	May 23 '25	Buy	10.60	10,000	105,995	86,681	May 23 04:35 PM
Melcher David F	Director	Feb 25 '25	Buy	13.67	13,000	177,646	76,681	Feb 25 04:26 PM

Open in Screener

MYO

Myomo Inc

Feb 13 • 04:00PM ET

0.8203

+0.0071 0.87 %

Healthcare • Medical Devices • USA • AMEX

Peers: ZBH INSP TNDM OFIX SRDX RCEL SIBN ATEC BLFS STXS

Index	RUT	P/E	-	EPS (ttm)	-0.29	Insider Own	7.40%	Shs Outstand	38.43M	Perf Week	2.14%
Market Cap	31.53M	Forward P/E	-	EPS next Y	-0.29	Insider Trans	6.03%	Shs Float	35.59M	Perf Month	-12.08%
Enterprise Value	31.28M	PEG	-	EPS next Q	-0.09	Inst Own	40.38%	Short Float	13.26%	Perf Quarter	-3.49%
Income	-12.02M	P/S	0.76	EPS this Y	-128.75%	Inst Trans	-14.13%	Short Ratio	7.30	Perf Half Y	-16.30%
Sales	41.64M	P/B	2.16	EPS next Y	20.77%	ROA	-47.71%	Short Interest	4.72M	Perf YTD	-9.86%
Book/sh	0.38	P/C	2.51	EPS next 5Y	-4.96%	ROE	-100.51%	52W High	6.39 -87.16%	Perf Year	-87.00%
Cash/sh	0.33	P/FCF	-	EPS past 3/5Y	55.74% 62.04%	ROIC	-48.32%	52W Low	0.71 15.37%	Perf 3Y	61.60%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	32.93% 53.36%	Gross Margin	66.56%	Volatility	6.55% 8.05%	Perf 5Y	-94.37%
Dividend TTM	-	EV/Sales	0.75	EPS Y/Y TTM	-25.54%	Oper. Margin	-28.51%	ATR (14)	0.07	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.10	Sales Y/Y TTM	64.99%	Profit Margin	-28.86%	RSI (14)	41.54	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.49	EPS Q/Q	-240.78%	SMA20	-5.68%	Beta	1.15	Target Price	5.00
Payout	-	Debt/Eq	0.84	Sales Q/Q	9.59%	SMA50	-12.98%	Rel Volume	0.26	Prev Close	0.81
Employees	185	LT Debt/Eq	0.70	Earnings	Nov 10 AMC	SMA200	-47.98%	Avg Volume	646.76K	Price	0.82
IPO	Jun 12, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	16.67% 6.92%	Trades		Volume	171,327	Change	0.87%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-31-24	Initiated	Craig Hallum	Buy	$7
May-20-24	Initiated	Lake Street	Buy	$7
Dec-15-23	Initiated	H.C. Wainwright	Buy	$6.50
Nov-11-20	Upgrade	ROTH Capital	Neutral → Buy	$5 → $7
May-27-20	Initiated	Dougherty & Company	Buy	$8.50
Oct-02-17	Initiated	H.C. Wainwright	Buy	$12

Nov-11-25 12:02AM	Myomo Inc (MYO) Q3 2025 Earnings Call Highlights: Strong International Growth Amidst Domestic ... (GuruFocus.com) -7.31%
Nov-10-25 05:35PM	Myomo, Inc. (MYO) Reports Q3 Loss, Tops Revenue Estimates (Zacks) +7.41%
Nov-06-25 07:20AM	Prestige Consumer Healthcare (PBH) Beats Q2 Earnings and Revenue Estimates (Zacks) -5.32%
Aug-12-25 03:00PM	Myomo Inc (MYO) Q2 2025 Earnings Call Highlights: Revenue Surge Amid Rising Costs and Strategic ... (GuruFocus.com) -38.64%
Aug-11-25 07:00PM	Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Loading…
04:05PM	Myomo Reports Second Quarter 2025 Financial and Operating Results (Business Wire)
Aug-08-25 09:32AM	Earnings To Watch: Myomo Inc (MYO) Reports Q2 2025 Result (GuruFocus.com)
Aug-04-25 04:05PM	Myomo to Report Second Quarter 2025 Financial Results on August 11 (Business Wire)
Jul-10-25 12:40AM	Myomo Reveals its $100 Revenue Goal During Investor Day (Insider Monkey)
Jun-25-25 08:56AM	Capricor (CAPR) Moves 20.4% Higher: Will This Strength Last? (Zacks)
Jun-18-25 08:30AM	Myomo Provides Highlights of Todays Investor & Analyst Day Event (Business Wire)
May-08-25 03:31AM	Myomo Inc (MYO) Q1 2025 Earnings Call Highlights: Record Revenue Surge and Strategic Innovations (GuruFocus.com) -30.58%
May-07-25 09:00PM	Myomo outlines 2025 revenue target of $50M-$53M amid advancements in product and marketing strategies (Seeking Alpha)
09:00PM	Myomo, Inc. (MYO) Q1 2025 Earnings Call Transcript (Seeking Alpha)
06:25PM	Myomo, Inc. (MYO) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
05:11PM	Loading…
05:11PM	Myomo Reports First Quarter 2025 Financial and Operating Results (Business Wire)
May-01-25 08:30AM	Myomo to Host Investor & Analyst Day Event on June 18, 2025 (Business Wire)
Apr-30-25 04:05PM	Myomo to Report First Quarter 2025 Financial Results on May 7 (Business Wire)
08:05AM	Myomo Launches the MyoPro® 2x (Business Wire)
Apr-10-25 08:30AM	Myomo Announces Upcoming Changes to its Board of Directors (Business Wire) -8.33%
Apr-09-25 06:03AM	Myomo: Balancing CMS Tailwinds With Long-Term Risks (Seeking Alpha) +5.41%
Mar-31-25 04:05PM	Myomo to Present at the 24th Annual Needham Virtual Healthcare Conference (Business Wire)
Mar-11-25 01:12PM	Q4 2024 Myomo Inc Earnings Call (Thomson Reuters StreetEvents) +40.77%
03:03AM	Myomo Inc (MYO) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Market ... (GuruFocus.com)
Mar-10-25 05:15PM	Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates (Zacks) -9.35%
04:05PM	Myomo's Fourth Quarter Financial Results Feature Record Revenue of $12.1 Million (Business Wire)
Mar-07-25 07:06AM	What To Expect From Myomo Inc (MYO) Q4 2024 Earnings (GuruFocus.com)
Mar-03-25 04:05PM	Myomo to Report Fourth Quarter 2024 Financial Results on March 10 (Business Wire) -5.33%
Dec-05-24 07:30AM	Myomo, Inc. Prices $15.0 Million Public Offering of Common Stock (Business Wire) +11.21%
Dec-04-24 04:05PM	Myomo, Inc. Announces Proposed Public Offering of Common Stock (Business Wire)
02:22AM	Loading…
Nov-07-24 02:22AM	Myomo Inc (MYO) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Initiatives (GuruFocus.com) +20.10%
Nov-06-24 06:00PM	Myomo, Inc. (MYO) Reports Q3 Loss, Tops Revenue Estimates (Zacks) +5.56%
04:05PM	Myomo Reports Record Third Quarter Financial and Operating Results (Business Wire)
Nov-05-24 08:07AM	Myomo Inc (MYO) Q3 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Oct-31-24 04:05PM	Myomo Announces First Private Payer Contracts for MyoPro In-network Coverage (Business Wire) -6.63%
Oct-30-24 04:05PM	Myomo to Report Third Quarter Financial Results on November 6, 2024 (Business Wire)
Oct-18-24 05:01PM	Rosalind Advisors, Inc. Expands Stake in Myomo Inc (GuruFocus.com)
Oct-09-24 05:08PM	Myomo Inc (MYO) Q2 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion ... (GuruFocus.com)
04:05PM	Myomo to Participate in the 2024 Maxim Healthcare Virtual Summit (Business Wire)
Sep-12-24 08:30AM	Myomo, Inc. Announces the Launch of Myomo Academy at AOPA National Assembly (Business Wire)
Sep-05-24 04:15PM	Myomo to Participate in Two Investor Conferences in September (Business Wire)
Aug-06-24 04:05PM	Myomo Reports Second Quarter 2024 Financial Results (Business Wire) -13.33%
Jul-30-24 04:05PM	Myomo to Report Second Quarter Financial Results on August 6, 2024 (Business Wire) -5.53% +7.21%
Jul-27-24 07:40AM	The 3 Best Robotic Exoskeleton Stocks to Buy Now (InvestorPlace)
Jul-26-24 06:05PM	Myomo, Inc. (MYO): Hedge Funds Are Bullish on This Robotics Stock Now (Insider Monkey)
Jul-08-24 08:30AM	Myomo Reports Preliminary Second Quarter 2024 Revenues and Operating Metrics (Business Wire) +41.81%
Jun-11-24 10:50AM	Sidoti Events, LLC's Virtual June Small-Cap Conference (ACCESSWIRE) +9.71%
Jun-05-24 05:58PM	Myomo to Present at the Sidoti Virtual Investor Conference on June 12-13, 2024 (Business Wire)
Jun-01-24 02:42AM	Director Thomas Kirk Acquires 50,000 Shares of Myomo Inc (MYO) (GuruFocus.com)
May-17-24 07:01PM	Insider Sale: Chief Medical Officer Harry Kovelman Sells 35,426 Shares of Myomo Inc (MYO) (GuruFocus.com)
May-10-24 04:03PM	Myomo Inc Reports Q1 2024 Earnings: Revenue Up Despite Challenges (GuruFocus.com) +7.58%
01:01PM	Myomo Inc (MYO) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth Amid Financial ... (GuruFocus.com)
May-09-24 01:16PM	Myomo, Inc. (AMEX:MYO) Q1 2024 Earnings Call Transcript (Insider Monkey) -9.41%
May-08-24 04:05PM	Myomo Reports First Quarter 2024 Financial Results (Business Wire) +8.56%
May-06-24 01:19PM	Myomo Receives Reimbursements For MyoPros from CMS (MT Newswires)
08:30AM	Myomo Announces First Lump Sum Reimbursements for MyoPros Delivered to Medicare Part B Beneficiaries Under New CMS Fees (Business Wire)
May-01-24 05:21PM	Myomo to Report First Quarter Financial Results on May 8, 2024 (Business Wire) +7.95% +11.05%
Mar-28-24 04:05PM	Myomo Appoints Heather Getz to its Board of Directors (Business Wire) -6.57% -5.50%
Mar-18-24 11:00AM	Director Thomas Kirk Acquires 50,000 Shares of Myomo Inc (MYO) (GuruFocus.com)
Mar-08-24 10:15AM	Myomo, Inc. (AMEX:MYO) Q4 2023 Earnings Call Transcript (Insider Monkey) -9.38%
Mar-07-24 06:00PM	Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Myomo Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
Mar-01-24 08:00AM	CMS Posts Final Medicare DMEPOS Fee Schedule Rate for the MyoPro® (Business Wire) +31.05%
Feb-29-24 04:05PM	Myomo to Report Fourth Quarter Financial Results on March 7, 2024 (Business Wire)
Jan-19-24 04:05PM	Myomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market (Business Wire) -6.33%
Jan-17-24 08:05AM	Myomo Announces $6 Million Registered Direct Offering of Common Stock Priced At-the-Market (Business Wire) +7.89%
08:00AM	Myomo Reports Preliminary Fourth Quarter Revenue and Backlog (Business Wire)
Dec-20-23 08:50AM	What Makes Myomo, Inc. (MYO) a Good Fit for 'Trend Investing' (Zacks) -19.21%
Dec-12-23 07:00AM	7 Stock Winners That Are Up 1,000% or More in 2023 (InvestorPlace)
Dec-01-23 10:00AM	Top Penny Stocks for Q4 2023 (Investopedia) +7.42%
Nov-20-23 04:16PM	3 Hot Penny Stocks to Buy in Q4 for Promising Potential (InvestorPlace) +5.88%
Nov-08-23 11:47AM	Myomo, Inc. (AMEX:MYO) Q3 2023 Earnings Call Transcript (Insider Monkey) +7.39%
Nov-07-23 04:05PM	Myomo Reports Third Quarter 2023 Financial Results Featuring Record Product Revenue and Authorizations (Business Wire) +6.02%
Nov-06-23 08:30AM	CMS Posts Proposed Medicare DMEPOS Fee Schedule Rate for the MyoPro® for Review at the Upcoming HCPCS Public Meeting (Business Wire) +21.17%
Nov-02-23 10:08AM	Myomo Announces that CMS has Classified the MyoPro Orthosis Under the Brace Benefit Category (Business Wire) +8.00%
Oct-31-23 04:05PM	Myomo to Report Third Quarter Financial Results on November 7, 2023 (Business Wire) +10.62%
Aug-29-23 04:05PM	Myomo Announces Closing of $4.4 Million Public Offering (Business Wire) -6.09%
Aug-28-23 12:38PM	Is Myomo (MYO) a Hidden Gem or a Value Trap? A Comprehensive Analysis (GuruFocus.com) +18.69%
Aug-25-23 07:00AM	Myomo Announces Pricing of $4.4 Million Public Offering (Business Wire) -10.13%
Aug-24-23 07:33PM	Myomo Inc (MYO): A Hidden Gem or a Potential Value Trap? (GuruFocus.com) +18.82%
04:15PM	Myomo, Inc. Announces Proposed Public Offering (Business Wire)
04:05PM	Myomo Receives Medicare Part B Reimbursement for First MyoPro® Claims (Business Wire)
Aug-21-23 04:05PM	Myomo Announces Two German Social Court Rulings Ordering MyoPro® Reimbursement (Business Wire) +10.80% -6.91%
Aug-09-23 05:30PM	Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +8.00% -7.67%
04:05PM	Myomo Reports Second Quarter 2023 Financial Results Featuring Year Over Year Growth in Revenue and Operating Metrics (Business Wire)
Aug-02-23 04:05PM	Myomo to Report Second Quarter Financial Results on August 9, 2023 (Business Wire) -7.02%
Jul-05-23 10:50AM	Myomo's (MYO) MyoPro Seeks CMS Classification for Medicare Cover (Zacks)
Jul-03-23 08:30AM	Centers for Medicare and Medicaid Services Accepts Myomos Application to Classify the MyoPro® as a Brace (Business Wire) +19.31%
Jun-14-23 04:05PM	Myomo To Participate in the Maxim Group Virtual Healthcare Conference Hosted by M-Vest (Business Wire) +6.27%
May-22-23 09:55AM	Here's Why Myomo, Inc. (MYO) Is a Great 'Buy the Bottom' Stock Now (Zacks)
May-10-23 06:05PM	Myomo, Inc. (MYO) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-09-23 07:05PM	Supernus Pharmaceuticals (SUPN) Q1 Earnings and Revenues Beat Estimates (Zacks)
May-05-23 07:45AM	Owens & Minor (OMI) Beats Q1 Earnings and Revenue Estimates (Zacks)
May-03-23 04:05PM	Myomo to Report First Quarter Financial Results on May 10, 2023 (Business Wire) -7.69%
Apr-10-23 08:30AM	Myomo Receives Technology License Fee Payment from China Joint Venture Company (Business Wire) +5.22%
Mar-16-23 05:30AM	SVB Collapse Spurs Finance Executives to Re-Evaluate Cash Strategies (The Wall Street Journal)
Mar-15-23 08:30AM	Myomo Makes NYSE American Section 610(b) Public Announcement (Business Wire)
Mar-14-23 11:11AM	Myomo, Inc. (AMEX:MYO) Q4 2022 Earnings Call Transcript (Insider Monkey) -6.84%
Mar-13-23 09:45AM	Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
08:30AM	Myomo Reports Fourth Quarter and Full Year 2022 Financial Results (Business Wire)

Myomo, Inc. is a wearable medical robotics company, which engages in the business of developing, designing, and producing myoelectric orthotics for people with neuromuscular disorders. The firm is also involved in selling products through various other sales channels including through orthotics and prosthetics providers, veterans' administration, and to distributors in certain accounts and geographic markets. The company was founded by Stephen Kelly, John McBean, Mira Sahney, and Kailas N. Narendran on September 1, 2004 and is headquartered in Burlington, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
KIRK THOMAS F	Director	Nov 20 '25	Buy	0.72	4,902	3,529	479,322	Nov 24 04:04 PM
KIRK THOMAS F	Director	Nov 21 '25	Buy	0.72	2,535	1,825	481,857	Nov 24 04:04 PM
Crowley Thomas Aloysius Jr.	Director	Nov 18 '25	Buy	0.73	4,000	2,938	75,748	Nov 21 07:22 PM
Crowley Thomas Aloysius Jr.	Director	Nov 19 '25	Buy	0.77	385	295	479	Nov 21 07:22 PM
KIRK THOMAS F	Director	Aug 25 '25	Buy	1.15	50,000	57,500	474,420	Aug 26 08:10 AM
KIRK THOMAS F	Director	Aug 18 '25	Buy	1.10	50,000	55,000	424,420	Aug 19 07:23 AM
GUDONIS PAUL R	Chief Executive Officer	Aug 15 '25	Buy	0.95	50,000	47,295	1,259,013	Aug 18 07:51 AM
David Henry	Officer	Jun 30 '25	Proposed Sale	2.19	23,587	51,656		Jun 30 08:12 PM
Harry Kovelman	Officer	Jun 28 '25	Proposed Sale	2.19	13,054	28,588		Jun 30 08:04 PM
Harry Kovelman	Officer	Jun 06 '25	Proposed Sale	2.97	5,743	17,057		Jun 06 07:08 PM
David Henry	Officer	Jun 06 '25	Proposed Sale	2.97	8,373	24,868		Jun 06 06:50 PM
KIRK THOMAS F	Director	May 15 '25	Buy	3.25	36,824	119,678	344,700	May 15 04:53 PM
KIRK THOMAS F	Director	May 14 '25	Buy	3.25	1,943	6,315	307,876	May 15 04:53 PM
GUDONIS PAUL R	Chief Executive Officer	May 15 '25	Buy	3.22	30,000	96,612	1,051,671	May 15 04:36 PM
KIRK THOMAS F	Director	May 12 '25	Buy	3.35	50,000	167,500	305,933	May 14 08:27 AM
KIRK THOMAS F	Director	Mar 13 '25	Buy	5.00	7,400	37,000	255,933	Mar 14 09:00 PM
Mitchell Micah	Chief Commercial Officer	Mar 14 '25	Sale	5.16	48,000	247,565	140,572	Mar 14 05:36 PM
MICAH MITCHELL	Officer	Mar 14 '25	Proposed Sale	5.16	48,000	247,565		Mar 14 05:24 PM
Kovelman Harry	Chief Medical Officer	Mar 12 '25	Sale	5.50	30,000	165,018	97,973	Mar 13 04:41 PM
Micah Mitchell	Officer	Mar 13 '25	Proposed Sale	5.22	1,283	6,697		Mar 13 04:31 PM
David Henry	Officer	Mar 13 '25	Proposed Sale	5.22	2,019	10,539		Mar 13 04:30 PM
Harry Kovelman	Officer	Mar 13 '25	Proposed Sale	5.22	1,496	7,809		Mar 13 04:28 PM
HARRY KOVELMAN	Officer	Mar 12 '25	Proposed Sale	5.50	30,000	165,015		Mar 12 04:59 PM

EMBC

Embecta Corp

MYO

Myomo Inc

Upgrade your FINVIZ experience